A: The Commission's independence rules apply to audits of financial statements required by SEC rules, except for those required by Rule 3-05 and 3-14 of Regulation S-X and Item 310(c) and (e) of Regulation S-B.
1 The Centers for Disease Control and Prevention (CDC) recommends 2 doses of quadrivalent meningococcal conjugate vaccine for adolescents 11 through 18 years of age.  The first dose should be given at 11 or 12 years of age, followed by a booster dose at age 16.
Who should get the meningitis (meningococcal) vaccine? All children ages 11-12, with a booster dose given at 16 years old (adolescents who receive the first dose between ages 13-15 should receive a booster dose between 16-18 years old)